CareDx, Inc. vs. Natera, Inc. Common Stock
Natera, Inc. Common Stock (NTRA) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CDNA | NTRA | |
|---|---|---|
| Market Cap | $2.81 billion | $52.80 billion |
| Revenue (TTM) | — | $2.71 billion |
| Net Income (TTM) | — | $-192,346,000 |
NTRA leads on 1 of 1 size & scale factors.
Valuation
| CDNA | NTRA | |
|---|---|---|
| Price / Book | — | 28.99 |
| Price / Sales | — | 19.50 |
CDNA and NTRA split the valuation factors evenly.
Profitability
| CDNA | NTRA | |
|---|---|---|
| Net Margin | — | -7.11% |
| Return on Equity | — | -10.56% |
CDNA and NTRA split the profitability factors evenly.
Risk & Sentiment
| CDNA | NTRA | |
|---|---|---|
| Short Interest | 7.55% | 0.96% |
NTRA leads on 1 of 1 risk & sentiment factors.
Dig deeper: CDNA overview, CDNA financials, NTRA overview, NTRA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.